Takeda closes in on a final $64B deal to buy Shire, starts to consider divestitures — reports
Takeda appears to be just hours away from completing a deal to buy Shire $SHPG at 49 pounds per share, creating a new top-10 pharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
